FindMyKOL
Clinical trialNCT02531035CompletedPhase 3Interventional

A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

SponsorLexicon PharmaceuticalsEnrollment1,405High Level of Sugar (Glucose) in the BloodType 1 Diabetes Mellitus (T1DM)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This Phase 3 study was designed to demonstrate the net benefit of sotagliflozin versus placebo in patients with Type 1 Diabetes (T1D).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

135 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Lexicon Investigational Site

    Córdoba, Córdoba Province, Argentina

  • Lexicon Investigational Site

    Buenos Aires, Argentina

  • Lexicon Investigational Site

    Buenos Aires, Argentina

Australia
  • Lexicon Investigational Site

    Coffs Harbour, New South Wales, Australia

  • Lexicon Investigational Site

    Merewether, New South Wales, Australia

  • Lexicon Investigational Site

    St Leonards, New South Wales, Australia

  • Lexicon Investigational Site

    Wollongong, New South Wales, Australia

  • Lexicon Investigational Site

    Herston, Queensland, Australia

  • Lexicon Investigational Site

    Keswick, South Australia, Australia

  • Lexicon Investigational Site

    Box Hill, Victoria, Australia

  • Lexicon Investigational Site

    Fitzroy, Victoria, Australia

  • Lexicon Investigational Site

    Parkville, Victoria, Australia

Belgium
  • Lexicon Investigational Site

    Aalst, Belgium

  • Lexicon Investigational Site

    Ghent, Belgium

  • Lexicon Investigational Site

    Sint-Niklaas, Belgium

Bulgaria
  • Lexicon Investigational Site

    Plovdiv, Bulgaria

  • Lexicon Investigational Site

    Rousse, Bulgaria

  • Lexicon Investigational Site

    Smolyan, Bulgaria

  • Lexicon Investigational Site

    Sofia, Bulgaria

  • Lexicon Investigational Site

    Sofia, Bulgaria

  • Lexicon Investigational Site

    Varna, Bulgaria

Canada
  • Lexicon Investigational Site

    Vancouver, British Columbia, Canada

  • Lexicon Investigational Site

    Halifax, Nova Scotia, Canada

  • Lexicon Investigational Site

    Barrie, Ontario, Canada

  • Lexicon Investigational Site

    London, Ontario, Canada

  • Lexicon Investigational Site

    Markham, Ontario, Canada

  • Lexicon Investigational Site

    Oakville, Ontario, Canada

  • Lexicon Investigational Site

    Thornhill, Ontario, Canada

  • Lexicon Investigational Site

    Toronto, Ontario, Canada

  • Lexicon Investigational Site

    Saint-Laurent, Quebec, Canada

  • Lexicon Investigational Site

    Sherbrooke, Quebec, Canada

Colombia
  • Lexicon Investigational Site

    Atlántico, Colombia

  • Lexicon Investigational Site

    Cundinamarca, Colombia

  • Lexicon Investigational Site

    Cundinamarca, Colombia

  • Lexicon Investigational Site

    Cundinamarca, Colombia

Czechia
  • Lexicon Investigational Site

    Krnov, Czechia

  • Lexicon Investigational Site

    Olomouc, Czechia

  • Lexicon Investigational Site

    Ostrava, Czechia

  • Lexicon Investigational Site

    Prague, Czechia

  • Lexicon Investigational Site

    Prague, Czechia

95 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSotagliflozin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
30 Apr 2017
Completion
30 Apr 2017
Last update posted
12 Feb 2020
Registered enrollment
1,405
Registry id
NCT02531035
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.